跳至主要内容
临床试验/IRCT20181028041485N1
IRCT20181028041485N1已完成3 期

efficacy of Diclofenac suppository on treatment of acute biliary pancreatitis

Sanandaj University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Acute pancreatitis, which in its definition should have at least two criteria of the following three criteria: a) pain in the upper abdomen, b) serum amylase or lipase> 3 times of normal, orc) acute pancreatitis features In computer tomography (CT) or magnetic resonance imaging (MRI)
  • A biliary cause based on at least one of the following conditions: a) gallstone or sludge in the imaging (any type); b) common bile duct > 8 mm in patients <75 years of age or> 10 mm in patients> 75 years of age. C) Alanine aminotransferase (AST) more than twice as normal;
  • Conscious informed consent;
  • Age older than 18 years.

排除标准

  • Cholangitis
  • Pancreatitis for other causes such as alcohol abuse, metabolic causes (hyperthermia or hypercalcemia), medication, trauma, etc.
  • Chronic pancreatitis

研究者

发起方
Sanandaj University of Medical Sciences

相似试验